Early cancer therapies

Marta Díez-Ferrer, Cristina Gutierrez, Antoni Rosell

Source: Eur Respir Monogr 2017; 78: 210-223

Congress or journal article abstractFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Marta Díez-Ferrer, Cristina Gutierrez, Antoni Rosell. Early cancer therapies. Eur Respir Monogr 2017; 78: 210-223

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Successful targeted therapy of advanced lung cancer
Source: Annual Congress 2013 –Grand Round on diagnostic and therapeutic challenges in thoracic oncology: an interactive session
Year: 2013


Targeted therapy for lung cancer
Source: Eur Respir J 2015; 46: 1239-1241
Year: 2015


Advances in target therapy for lung cancer
Source: International Congress 2014 – Ceremony for the ERS Romain Pauwels Research Award 2014 - Clinical Year in Review I
Year: 2014



Advances in target therapy in lung cancer
Source: Eur Respir Rev 2015; 24: 23-29
Year: 2015



Innovative local therapies in lung cancer
Source: International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy
Year: 2018


Multimodality lung cancer therapy – nonsurgical complications
Source: Annual Congress 2008 - High-risk patients for major lung cancer surgery
Year: 2008


Early cancer detection
Source: Eur Respir Monogr 2017; 78: 89-102
Year: 2017


Early cancer detection
Source: Annual Congress 2008 - Interventional pneumology – what went wrong and what was never published
Year: 2008


PG11 Modern approaches in lung cancer diagnostics and therapy
Source: Paris 2018 - Educational material
Year: 2018

Innovative systemic lung cancer therapies
Source: International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy
Year: 2018


Current neoadjuvant/adjuvant treatment for advanced stage lung cancer
Source: International Congress 2014 – PG19 Surgery for advanced stage lung cancer
Year: 2014

New and anticipated therapeutic developments in management of non-small-cell lung cancer
Source: Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer
Year: 2013


Novel approaches in metastasised non-small cell lung cancer with a special focus on modern systemic therapies
Source: International Congress 2019 – State of the art session: Thoracic oncology
Year: 2019


Modern profiling of advanced lung cancer at the primary diagnosis and during therapy
Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer
Year: 2018


Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer
Source: Eur Respir J 2013; 42: 1119-1133
Year: 2013



Cardiovascular effects of innovative therapies in lung cancer
Source: Eur Respir Monogr 2020; 88: 154-166
Year: 2020


Early stage nonsmall-cell lung cancer: therapeutic options (surgery, adjuvant and neoadjuvant therapy)
Source: Annual Congress 2011 - PG10 Management of thoracic tumours in practice: a HERMES basic course
Year: 2011